日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Attributes and Health Care Resource Utilization of Patients on Enzalutamide or Abiraterone for Metastatic Castration-Resistant Cancer in England

英格兰接受恩扎卢胺或阿比特龙治疗的转移性去势抵抗性癌症患者的特征和医疗资源利用情况

Bahl, Amit; Faria, Rita; Merseburger, Axel S; Attard, Gert; Snijder, Robert; Sodatonou, Hanna; Stark, Sari; Pranzo, Alessandra; Martins, Karla; Rozario, Nigel; Ridsdale-Smith, Jess; Chilelli, Andrew

Diagnostic Performance and Clinical Utility of the Uromonitor(®) Molecular Urine Assay for Urothelial Carcinoma of the Bladder: A Systematic Review and Diagnostic Accuracy Meta-Analysis

Uromonitor® 分子尿液检测在膀胱尿路上皮癌诊断中的诊断性能和临床应用价值:系统评价和诊断准确性荟萃分析

Rodas Garzaro, Julio Ruben; Kravchuk, Anton; Burger, Maximilian; Wolff, Ingmar; Lebentrau, Steffen; Rubio-Briones, José; Brás, João Paulo; Gilfrich, Christian; Siepmann, Stephan; Pahernik, Sascha; Merseburger, Axel S; Heidenreich, Axel; May, Matthias

Using ChatGPT-4 for Lay Summarization in Prostate Cancer Research to Advance Patient-Centered Communication: Large-Scale Generative AI Performance Evaluation

利用 ChatGPT-4 进行前列腺癌研究的通俗易懂的摘要生成,以促进以患者为中心的沟通:大规模生成式人工智能性能评估

Rinderknecht, Emily; Engelmann, Simon U; Saberi, Veronika; Kirschner, Clemens; Kravchuk, Anton P; Schmelzer, Anna; Breyer, Johannes; Goßler, Christopher; Mayr, Roman; Gilfrich, Christian; Burger, Maximilian; von Winning, Dominik; Borgmann, Hendrik; Wülfing, Christian; Merseburger, Axel S; Haas, Maximilian; May, Matthias

Spatial transcriptomics exploration of the primary neuroblastoma microenvironment in archived FFPE samples unveils novel paracrine interactions.

对存档的 FFPE 样本中原发性神经母细胞瘤微环境的空间转录组学探索揭示了新的旁分泌相互作用。

Siaw Joachim T, Merseburger Peter, Borenäs Marcus, Jansson Caroline, Karlsson Jenny, Claeys Arne, Jennische Eva, Lind Dan E, Gisselsson Nord David, Palmer Ruth H, Van den Eynden Jimmy

Ultralow Prostate-specific Antigen Nadir After Apalutamide: Outcomes in Synchronous Versus Metachronous Metastatic Hormone-sensitive Prostate Cancer

阿帕鲁胺治疗后前列腺特异性抗原最低值超低:同步性与异时性转移性激素敏感性前列腺癌的疗效

Wenzel, Mike; Steuber, Thomas; Siech, Carolin; Kriegmair, Maximilian; Hoeh, Benedikt; Tilki, Derya; Merseburger, Axel S; Chun, Felix K H; Mandel, Philipp

An international multicentre randomised controlled trial of en bloc resection of bladder tumour vs conventional transurethral resection of bladder tumour: first results of the en bloc resection of urothelium carcinoma of the bladder (EBRUC) II trial

一项国际多中心随机对照试验,比较膀胱肿瘤整块切除术与传统经尿道膀胱肿瘤切除术:膀胱尿路上皮癌整块切除术(EBRUC)II期试验的初步结果

Struck, Julian Peter; Moharam, Nadim; Leitenberger, Armin; Weber, Jörg; Lusuardi, Lukas; Oswald, David; Rassweiler, Jens J; Fiedler, Marcel; Horňák, Jakub; Babjuk, Marek; Micali, Salvatore; Zaraca, Carlo; Spreu, Thomas; Friedersdorff, Frank; Borgmann, Hendrik; Merseburger, Axel S; Kramer, Mario W

Guiding first-line treatment decisions in advanced urothelial carcinoma: a global survey

指导晚期尿路上皮癌一线治疗决策:一项全球调查

Grande, Enrique; Bellmunt, Joaquim; Hussain, Syed A; Al Mansour, Mubarak M; Bamias, Aristotle; Barthélémy, Philippe; Benjamin, David J; Blais, Normand; Bourlon, Maria T; Castellano, Daniel; Danchaivijitr, Pongwut; Fernandez Lazzaro, Mauricio; Giannatempo, Patrizia; Guerrero-Ramos, Félix; Iacovelli, Roberto; Ivanyi, Philipp; Jung, Eun Hee; Kanesvaran, Ravindran; Manneh, Ray; Marinho, Joana C; Matsubara, Nobuaki; Merseburger, Axel S; Mukherji, Deborah; Park, Chandler H; Tran, Ben; da Trindade, Karine Martins; Ürün, Yüksel; Kamat, Ashish M; Birtle, Alison J

Cardiovascular Risks and Survival with Abiraterone vs Enzalutamide in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer in Germany: AVENGER Study

德国一项AVENGER研究比较了阿比特龙与恩扎卢胺在未经化疗的转移性去势抵抗性前列腺癌患者中的心血管风险和生存率。

Merseburger, Axel S; Dornstauder, Eugen; Ohlmann, Carsten-Henning; Aprikian, Armen; Junker, Sophia; Hahn, Philipp; Chilelli, Andrew; Stoelzel, Matthias; Serikoff, Alexis; Spitzer, Stefan G

Association between major cardiovascular events and abiraterone acetate compared to enzalutamide in patients with metastatic castration-resistant prostate cancer: a post hoc analysis of the EVADE study

在转移性去势抵抗性前列腺癌患者中,与恩扎卢胺相比,醋酸阿比特龙与主要心血管事件的关联性:EVADE 研究的事后分析

Bahl, Amit; Chilelli, Andrew; Faria, Rita; Rozario, Nigel; Snijder, Robert; Stark, Sari; Merseburger, Axel S

Reply to Parth Aphale, Shashank Dokania, Himanshu Shekhar's Letter to the Editor re: Bahl A, Chilelli A, Faria R, et al. Association between major cardiovascular events and abiraterone acetate compared to enzalutamide in patients with metastatic castration-resistant prostate cancer: a post hoc analysis of the EVADE study. World J Urol 43:465. https://doi.org/10.1007/s00345-025-05841-9

回复 Parth Aphale、Shashank Dokania 和 Himanshu Shekhar 致编辑的信,内容关于 Bahl A、Chilelli A、Faria R 等人发表的题为“转移性去势抵抗性前列腺癌患者中,醋酸阿比特龙与恩扎卢胺相比,主要心血管事件的关联性:EVADE 研究的事后分析”的文章。该文章发表于《世界泌尿外科杂志》43:465。https://doi.org/10.1007/s00345-025-05841-9

Bahl, Amit; Chilelli, Andrew; Faria, Rita; Rozario, Nigel; Snijder, Robert; Stark, Sari; Merseburger, Axel S